Safety and Efficacy of Low-Dose Prednisolone with Pirfenidone in Idiopathic Pulmonary Fibrosis

被引：0

作者：

Matsubayashi, S. ^{[1
]}

Izumi, S. ^{[1
]}

Takumida, H. ^{[1
]}

Watanabe, H. ^{[1
]}

Matsumoto, S. ^{[1
]}

Kusaba, Y. ^{[1
]}

Katsuno, T. ^{[1
]}

Kakuwa, T. ^{[1
]}

Tsujimoto, Y. ^{[1
]}

Sakamoto, K. ^{[1
]}

Hashimoto, M. ^{[1
]}

Ishii, S. ^{[1
]}

Morino, E. ^{[1
]}

Suzuki, M. ^{[1
]}

Takasaki, J. ^{[1
]}

Naka, G. ^{[1
]}

Iikura, M. ^{[1
]}

Takeda, Y. ^{[1
]}

Sugiyama, H. ^{[1
]}

机构：

[1] Natl Ctr Global Hlth & Med, Resp Med, Tokyo, Japan

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4769

引用

页数：1

共 50 条

[31] Pirfenidone in idiopathic pulmonary fibrosis
Kagouridis, Konstantinos
Manali, Effrosyni D.
Kolilekas, Likourgos
Triantafillidou, Christina
Papiris, Spyros A.
PNEUMON, 2012, 25 (02) : 145 - 147
[32] Pirfenidone for idiopathic pulmonary fibrosis
Antoniu, Sabina A.
Donner, Claudio F.
MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2009, 4 (05): : 350 - 353
[33] Pirfenidone for idiopathic pulmonary fibrosis
Bouros, Demosthenes
LANCET, 2011, 377 (9779): : 1727 - 1729
[34] Idiopathic pulmonary fibrosis and pirfenidone
Collard, H. R.
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) : 728 - 729
[35] Pirfenidone in idiopathic pulmonary fibrosis
Taniguchi, H.
Ebina, M.
Kondoh, Y.
Ogura, T.
Azuma, A.
Suga, M.
Taguchi, Y.
Takahashi, H.
Nakata, K.
Sato, A.
Takeuchi, M.
Raghu, G.
Kudoh, S.
Nukiwa, T.
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) : 821 - 829
[36] Pirfenidone in idiopathic pulmonary fibrosis
Nicod, LP
LANCET, 1999, 354 (9175): : 268 - 269
[37] Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis
Agrawal, Neha
Vaidya, Preyas J.
Chavhan, Vinod B.
Lele, Tejashree T.
Leuppi-Taegtmeyer, Anne
Leuppi, Joerg D.
Chhajed, Prashant N.
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[38] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
Flaherty, Kevin R.
Fell, Charlene D.
Huggins, J. Terrill
Nunes, Hilario
Sussman, Robert
Valenzuela, Claudia
Petzinger, Ute
Stauffer, John L.
Gilberg, Frank
Bengus, Monica
Wijsenbeek, Marlies
EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
[39] Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lancaster, Lisa H.
de Andrade, Joao A.
Zibrak, Joseph D.
Padilla, Maria L.
Albera, Carlo
Nathan, Steven D.
Wijsenbeek, Marlies S.
Stauffer, John L.
Kirchgaessler, Klaus-Uwe
Costabel, Ulrich
EUROPEAN RESPIRATORY REVIEW, 2017, 26 (146):
[40] SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Flaherty, K. R.
Fell, C. D.
Huggins, J. T.
Nunes, H.
Sussman, R.
Valenzuela, C.
Petzinger, U.
Stauffer, J. L.
Gilberg, F.
Bengus, M.
Wijsenbeek, M.
THORAX, 2017, 72 : A253 - A254

← 1 2 3 4 5 →